Implementing and evaluating a fully functional AI-enabled model for chronic eye disease screening in a real clinical environment

Christos Skevas,Nicolás Pérez de Olaguer,Albert Lleó,David Thiwa,Ulrike Schroeter,Inês Valente Lopes,Luca Mautone,Stephan J. Linke,Martin Stephan Spitzer,Daniel Yap,Di Xiao
DOI: https://doi.org/10.1186/s12886-024-03306-y
IF: 2.086
2024-02-04
BMC Ophthalmology
Abstract:Artificial intelligence (AI) has the potential to increase the affordability and accessibility of eye disease screening, especially with the recent approval of AI-based diabetic retinopathy (DR) screening programs in several countries.
ophthalmology
What problem does this paper attempt to address?
### Problems the Paper Aims to Solve This paper aims to study the feasibility of implementing and evaluating an integrated hardware and software solution and its automated workflow in a real clinical environment. Specifically, the study focuses on the following points: 1. **System Performance and Diagnostic Performance**: Evaluate the overall system solution from patient recruitment to retinal image acquisition and AI grading of diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucoma. 2. **Comparison of Expert Review Results with AI Grading Results**: Compare and analyze the grading results of experts with those of AI. 3. **User Feedback Collection**: Collect user feedback on the system. Through these evaluations, the researchers hope to explore the feasibility and acceptability of AI-assisted chronic eye disease screening and understand the challenges and opportunities faced in the actual deployment of AI technology in ophthalmic disease screening and management. ### Research Background With the increasing prevalence of diabetic retinopathy, glaucoma, and age-related macular degeneration worldwide, the necessity for early detection and management of these diseases is becoming more prominent. Traditionally, the screening and diagnosis of these diseases have relied mainly on ophthalmologists manually examining and interpreting retinal images. However, this process is not only time-consuming and resource-intensive but also prone to observer variability and human error. In recent years, the application of artificial intelligence, especially deep learning technology, in the field of ophthalmology has shown great potential. AI algorithms have demonstrated high accuracy in automating the grading of diabetic retinopathy, age-related macular degeneration, and glaucoma using retinal images. These advancements not only improve diagnostic accuracy and efficiency but also reduce the burden on healthcare systems and enhance patient outcomes. Nevertheless, the application of these technologies in real clinical environments still faces many challenges, requiring further research to validate their effectiveness and user experience.